scispace - formally typeset
H

Hamid Reza Baradaran

Researcher at Iran University of Medical Sciences

Publications -  201
Citations -  3531

Hamid Reza Baradaran is an academic researcher from Iran University of Medical Sciences. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 27, co-authored 169 publications receiving 2531 citations. Previous affiliations of Hamid Reza Baradaran include University of Glasgow & University of Hamburg.

Papers
More filters
Journal ArticleDOI

Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis

Brooke Levis, +148 more
- 09 Jun 2020 - 
TL;DR: The combination was estimated to reduce the number of participants needing to complete the full PHQ-9 by 57% (56%-58%) and to understand the clinical and research value of this combined approach to screening.
Journal ArticleDOI

Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: A systematic review and individual participant data meta-analysis

Yin Wu, +78 more
TL;DR: Sensitivity may be minimally reduced with the PHQ-8, but specificity is similar, and bivariate random-effects models to assess diagnostic accuracy were similar.
Journal ArticleDOI

Psychological distress among bam earthquake survivors in iran: a population-based study

TL;DR: The study findings indicated that the amount of psychological distress among earthquake survivors was high and there is an urgent need to deliver mental health care to disaster victims in local medical settings and to reduce negative health impacts of the earthquake adequate psychological counseling is needed.
Journal ArticleDOI

Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis

TL;DR: The prevalence of type 2 diabetes appears higher in the Islamic Republic of Iran than in other developing countries but because of differences in age pyramids, the crude prevalence is not an appropriate indicator and age-adjusted or age-specific prevalences should be used.
Journal ArticleDOI

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran

TL;DR: T2DM is a costly disease in the Iran healthcare system and consume more than 8.69% of total health expenditure, in addition to these quantified costs, T2DM imposes high intangible costs on society in terms of reduced quality of life.